Nektar Therapeutics Plunging 9% In Pre-Market

Nektar Therapeutics NKTR is dropping 9% in pre-market trading. Volume is particularly thin this morning. It's trading down $1.26 to $12.80, a loss of 8.96%. Nektar Therapeutics focuses on developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms.